• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3DR; BREAST - ABSORBABLE MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEPHA, INC. - 3005670760 GALAFLEX 3DR; BREAST - ABSORBABLE MESH Back to Search Results
Model Number 100043-02
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes Unspecified Infection (1930); Seroma (2069); Impaired Healing (2378)
Date of Event 10/05/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Based on the information provided, no conclusions can be made.As reported, patient was diagnosed with post-op complications of seroma, infection and delayed wound healing.Medical affairs has assessed the patient¿s postoperative course as being serious and likely related to the study device.Review of the device history records confirmed the device was manufactured to specification.Seroma and infection are known inherent risk of the surgery/use of the device and included as a possible complication in the adverse reaction section of the instruction for use (ifu).In regards to infection, the warnings section of the ifu states, "if an infection develops, treat the infection aggressively.An unresolved infection may require removal of the scaffold." note: this mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr. all safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness. in an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.
 
Event or Problem Description
Per clinical trial cp-1060: on (b)(6) 18, patient underwent bilateral augmentation mastopexy using a full vertical and horizontal t incision.2 pieces of galaform (galaflex 3dr) were used.No concomitant procedures were done.On (b)(6) 18, right breast seroma and infection was reported.Patient had culture taken and was treated with medication (bactrim).Resolved without sequelae on (b)(6) 18.On (b)(6) 18, delayed wound healing; right t region, was reported.Patient treated with dressing changes.Resolved without sequelae on (b)(6) 18.Review by medical affairs identifies the seroma, infection and delayed wound healing are likely related to the device and serious.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAFLEX 3DR
Common Device Name
BREAST - ABSORBABLE MESH
Manufacturer (Section D)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer (Section G)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key14984998
Report Number1213643-2022-00501
Device Sequence Number16543536
Product Code OOD
UDI-Device Identifier00855920006232
UDI-Public(01)00855920006232
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K162922
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/19/2018
Device Model Number100043-02
Device Catalogue NumberFR3D02
Device Lot Number170511
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/05/2022
Initial Report FDA Received Date07/12/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/03/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age38 YR
Patient SexFemale
Patient Weight71 KG
-
-